课题基金 / 基金详情

Bik Promotes Cleavage of Viral Proteins to Enhance Influenza A Virus Infection

Bik Promotes Cleavage of Viral Proteins to Enhance Influenza A Virus Infection
Bik 促进病毒蛋白裂解,增强甲型流感病毒感染
批准号:
8969925
负责人:
Yohannes Afework Mebratu
金额:
$27.25万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-05-01 至 2017-04-30

项目摘要

项目成果

Yohannes Afework Mebratu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): Influenza (flu) is a highly contagious respiratory disease that affects millions of people each year with significant cost to the economy. Currently, influenza A virus (IAV) of the subtype H1N1 is responsible for seasonal epidemics that may result in severe respiratory illness and deaths worldwide. The annual Influenza virus epidemics are estimated to cost the U.S. 10.4 billion in direct medical expenses and 16.4 billion in lost potential earnings. The frequent appearances of new strains of flu made the generation of effective vaccines difficult. Therefore, the detailed molecular mechanisms how IAV replicates and propagates need to be investigated to design effective antiviral drugs and vaccines. Influenza induces cell death in infected cells to facilitate virus replication. Our preliminary studies identified the Bcl-2 interacting killer (Bik) as a crucial cellular protein promoting IAV infection in human airway epithelial cells (AECs) and in mice. We found that IAV replication was attenuated in bik-/- compared to bik+/+ cells, as indicated by reduced viral titers. Following infection, bik-deficient mouse airway epithelial cells (MAECs) showed more stable trans-epithelial resistance following infection, were less sensitive to infection-induced cell death, and had reduced levels of viral RNA compared to bik-sufficient MAECs. Knockdown of Bik reduced viral protein expression levels and the sensitivity of human airway epithelial cells (HAECs) to IAV-induced cell death. Survival analysis of mice infected with IAV showed that bik-/- mice survived for significantly longer days after infection and were 10-fold less likely to die from infection compared to bik+/+ mice. Additionally, the bik+/+ mice lost significantly more weight compared to the bik-/- mice. IAV activated caspase 3 in a Bik-dependent manner and cleavage of viral NP and M2 proteins were inhibited when Bik was knocked down, implying that Bik-mediated caspase cleavage of viral proteins is linked to virus replication. Thus, we hypothesize that Bik is crucial for intracellular cleavage of components of viral protein(s) to promote virus replication. Although cleavage of viral proteins has been shown to promote virus infectivity, littl is known about relevant host cell proteases. This study will investigate the role of caspases in enhancing virus infectivity and tests whether targeted inhibition of caspases mitigate IAV infectivity. This hypothesis will be tested in Specific Aims 1 and 2. Aim 1 will investigate whethe Bik mediates caspase-dependent cleavage of viral proteins in IAV infected cells. Aim 2 will determine whether modulating the expression of Bik or inhibition of caspase activations mitigate viral replication and susceptibility to IAV- induced mortality in vivo. A better understanding of te molecular mechanisms how IAV manipulates host cellular proteins to facilitate virus replication will provide insight into new therapeutic approaches that target cellular and/or viral proteins to reduce infection and disease progression in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of Bik in the replication and severity of influenza A virus
  • 批准号:
    10701133
  • 项目类别:
  • 资助金额:
    $15.1万
  • 财政年份:
    2022
  • 负责人:
    Yohannes Afework Mebratu
  • 依托单位:
The role of Bik in the replication and severity of influenza A virus
  • 批准号:
    10543562
  • 项目类别:
  • 资助金额:
    $40.25万
  • 财政年份:
    2021
  • 负责人:
    Yohannes Afework Mebratu
  • 依托单位:
The role of Bik in the replication and severity of influenza A virus
  • 批准号:
    10322448
  • 项目类别:
  • 资助金额:
    $29.19万
  • 财政年份:
    2021
  • 负责人:
    Yohannes Afework Mebratu
  • 依托单位:
海外基金